Connection

Konstantinos Syrigos to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Antineoplastic Combined Chemotherapy Protocols.
Konstantinos Syrigos
Connection Strength
0.334
Antineoplastic Combined Chemotherapy Protocols
  1. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
    View in: PubMed
    Score: 0.095
  2. A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer. Lung Cancer. 2019 10; 136:52-56.
    View in: PubMed
    Score: 0.094
  3. Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer. Lung Cancer. 2017 10; 112:126-133.
    View in: PubMed
    Score: 0.081
  4. Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer. Curr Med Res Opin. 2019 10; 35(10):1761-1767.
    View in: PubMed
    Score: 0.023
  5. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Med Oncol. 2018 May 31; 35(7):101.
    View in: PubMed
    Score: 0.022
  6. Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. Lung Cancer. 2017 07; 109:101-108.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.